Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
OBJECTIVES: The Korea National Health and Nutrition Examination Survey (KNHANES) is a nationwide cross-sectional surveillance system that assesses the health and nutritional status of the Korean population. To evaluate the occurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the community, we investigated the prevalence of antiSARS-CoV-2 antibodies in the sera of KNHANES participants. METHODS: Subjects were recruited between April 24 and December 12, 2020. In total, 5,284 subjects aged 10-90 years from 17 regions participated. SARS-CoV-2 antibodies were screened using the Elecsys Anti-SARS-CoV-2 assay. Positive samples were verified using 4 different SARS-CoV-2 antibody assays and the plaque reduction neutralizing test. The final seropositivity criteria were a positive screening test and at least 1 positive result from the 5 additional tests. RESULTS: Almost half (49.2%; 2,600/5,284) of participants were from metropolitan areas, 48.9% were middle-aged (40-69 years), and 20.5% were in their 20s or younger. The seropositivity rate was 0.09% (5/5,284). Three of the 5 antibody-positive subjects had a history of infection, of whom 2 were infected abroad and 1 was infected in a local cluster outbreak. CONCLUSIONS: The low SARS-CoV-2 antibody seroprevalence in Korea indicates that there have been few coronavirus disease 2019 (COVID-19) cases due to successful COVID-19 management measures (e.g., diagnostic tests for overseas arrivals, national social distancing, and strict quarantine measures). Moreover, asymptomatic infections were uncommon due to active polymerase chain reaction testing. However, hidden infections may exist in the community, requiring the continuation of quarantine and vaccination measures.
Abstract
OBJECTIVES: The Korea National Health and Nutrition Examination Survey (KNHANES) is a nationwide cross-sectional surveillance system that assesses the health and nutritional status of the Korean population. To evaluate the occurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the community, we investigated the prevalence of antiSARS-CoV-2 antibodies in the sera of KNHANES participants. METHODS: Subjects were recruited between April 24 and December 12, 2020. In total, 5,284 subjects aged 10-90 years from 17 regions participated. SARS-CoV-2 antibodies were screened using the Elecsys Anti-SARS-CoV-2 assay. Positive samples were verified using 4 different SARS-CoV-2 antibody assays and the plaque reduction neutralizing test. The final seropositivity criteria were a positive screening test and at least 1 positive result from the 5 additional tests. RESULTS: Almost half (49.2%; 2,600/5,284) of participants were from metropolitan areas, 48.9% were middle-aged (40-69 years), and 20.5% were in their 20s or younger. The seropositivity rate was 0.09% (5/5,284). Three of the 5 antibody-positive subjects had a history of infection, of whom 2 were infected abroad and 1 was infected in a local cluster outbreak. CONCLUSIONS: The low SARS-CoV-2 antibody seroprevalence in Korea indicates that there have been few coronavirus disease 2019 (COVID-19) cases due to successful COVID-19 management measures (e.g., diagnostic tests for overseas arrivals, national social distancing, and strict quarantine measures). Moreover, asymptomatic infections were uncommon due to active polymerase chain reaction testing. However, hidden infections may exist in the community, requiring the continuation of quarantine and vaccination measures.
참고문헌 (22)
- "COVID-19 – China" (2020)[URL]
- "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)" (2020)[URL]
- "WHO coronavirus (COVID-19) dashboard"[URL]
- "COVID-19 - Republic of Korea - (ex-China)" (2020)[URL]
- "Coronavirus (COVID-19), Republic of Korea"[URL]
- "Coronavirus (COVID-19), Republic of Korea. Cases in Korea"[URL]
- "Tackling COVID-19 health, quarantine and economic measures: Korean experience" (2020)[URL]
- Gao Z, "A systematic review of asymptomatic infections with COVID-19", J Microbiol Immunol Infect, 54, pp.12~16 (2021)
- 기모란, "Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea", Epidemiology and Health, 42, pp.1~7 (2020), 한국역학회[DOI]
- Park Yoojin, "Application of Testing-Tracing-Treatment Strategy in Response to the COVID-19 Outbreak in Seoul, Korea", Journal of Korean Medical Science, 35(45), pp.1~9 (2020), 대한의학회[DOI]
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
- "Evaluation of Roche Elecsys antiSARS-CoV-2 S serology assay for the detection of anti-SARS-CoV-2 S antibodies" (2021)[URL]
- Bendavid E, "COVID-19 antibody seroprevalence in Santa Clara County, California", Int J Epidemiol, 50, pp.410~419 (2021)
- Sood N, "Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10-11, 2020", JAMA, 323, pp.2425~2427 (2020)
- Menachemi N, "Population point prevalence of SARS-CoV-2 infection based on a statewide random sample-Indiana, April 25-29, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.960~964 (2020)
- Angulo FJ, "Estimation of US SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys", JAMA Netw Open, 4, pp.e2033706~ (2021)
- "Weekly coronavirus disease 2019 (COVID-19) surveillance report: summary of COVID-19 surveillance systems; week 40" (2020)[URL]
- Duan S, "Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China", PLoS Negl Trop Dis, 15, pp.e0008975~ (2021)
- Nawa N, "Seroprevalence of SARS-CoV-2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020", J Gen Fam Med, 22, pp.160~162 (2020)
- Nah EH, "Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea : a cross-sectional study", BMJ Open, 11, pp.e049837~ (2021)
- "EUA authorized serology test performance"[URL]
- Legros V, "A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity", Cell Mol Immunol, 18, pp.318~327 (2021)